Annex II
Current membership of the International Narcotics Control Board
Hamid Ghodse
Born in 1938. National of the Islamic Republic of Iran. Professor of Psychiatry and of International Drug Policy, University of London (since 1987). Director, International Centre for Drug Policy, St. George’s University of London (since 2003); President, European Collaborating Centres for Addiction Studies (since 1992); Non-Executive Director, National Patient Safety Agency, United Kingdom (since 2001); Chairman, Higher Degrees in Psychiatry, University of London (since 2003); Chairman, Honours Committee, Royal College of Psychiatrists, United Kingdom (since 2006).
Recipient of the following degrees, qualifications and awards: Doctor of Medicine (M.D.), Islamic Republic of Iran (1965); Diploma Psychological Medicine (D.P.M.), United Kingdom (1974); Doctor of Philosophy (Ph.D.), University of London (1976); and Doctor of Science (D.Sc.), University of London (2002). Fellow of the Royal College of Psychiatrists (F.R.C.Psych.), United Kingdom (1985); Fellow of the Royal College of Physicians (F.R.C.P.), London (1992); Fellow of the Royal College of Physicians of Edinburgh (F.R.C.P.E.), Edinburgh (1997); Fellow of the Faculty of Public Health Medicine (F.F.P.H.), United Kingdom (1997); Fellow of the Higher Education Academy (F.H.E.A.), United Kingdom (2005); International Fellow, American Psychiatric Association (APA) (2009). Honorary Fellow, Royal College of Psychiatrists (R.C.Psych.) (2006); Honorary Fellow, World Psychiatric Association (2008). Member of the World Health Organization (WHO) Expert Advisory Panel on Alcohol and Drug Dependence (since 1979); Adviser, Joint Formulary Committee, British National Formulary (since 1984); Honorary Consultant Psychiatrist, St. George’s and Springfield University Hospitals, London (since 1978); Honorary Consultant Public Health, Wandsworth Primary Care Trust, London (since 1997). Consultant Psychiatrist, St. Thomas’s Teaching Hospital and Medical School, London (1978-1987); member, rapporteur, chairman and convener of various WHO and European
Community expert committees, review groups and other working groups on drug and alcohol dependence; M. S. McLeod Visiting Professor, Southern Australia (1990); Honorary Professor, Peking University (since 1997). Author or editor of over 300 scientific books and papers on drug-related issues and addictions, including the following books: The Misuse of Psychotropic Drugs, London (1981); Psychoactive Drugs and Health Problems, Helsinki (1987); Psychoactive Drugs: Improving Prescribing Practices, Geneva (1988); Substance Abuse and Dependence, Guildford (1990); Drug Misuse and Dependence: The British and Dutch Response, Lancashire, United Kingdom (1990); Misuse of Drugs (3rd ed.), London (1997); Young People and Substance Misuse, London (2004); Addiction at Workplace, Aldershot (2005); International Drug Control into the 21st Century, Aldershot (2008). Ghodse’s Drugs and Addictive Behaviour: A Guide to Treatment (4th ed.), Cambridge (2010); Editor-in-Chief, International Psychiatry; Honorary Editor-in-Chief Chinese Journal of Drug Dependence; member of the Editorial Board, International Journal of Social Psychiatry; member of the Editorial Board, Asian Journal of Psychiatry. Convener of WHO expert groups on medical education (1986), pharmacy education (1987), nurse education (1989) and rational prescribing of psychoactive drugs. Chairman, Association of Professors of Psychiatry of the British Isles (since 1991); Chairman, Association of European Professors of Psychiatry; Director, National Programme on Substance Abuse Deaths (since 1997); member of the International Association of Epidemiology (since 1998).
Member of the International Narcotics Control Board (since 1992). Member of the Standing Committee on Estimates (1992). President of the Board (1993, 1994, 1997, 1998, 2000, 2001, 2004, 2005, 2008 and 2010).
132
Annex II. Current membership of the International Narcotics Control Board
Galina Korchagina
Born in 1953. National of the Russian Federation. Deputy Director of Research at the National Centre for Research on Drug Addiction, Ministry of Health and Social Development, Russian Federation (since 2010).
Leningrad    Paediatrics    Institute,    Russian
Federation (1976); doctor of medicine (2001). Doctor, boarding school, Gatchina, Leningrad region (1976-1979). Head of the Organizational and Policy Division, Leningrad Regional Drug Clinic (1981-1989); Lecturer, Leningrad Regional Medical Academy (1981-1989); Head Doctor, City Drug Clinic, St. Petersburg (1989-1994); Assistant Lecturer (1991- 1996) and Professor (2000-2001), Department of Social Technologies, State Institute for Services and Economics; Assistant Lecturer (1994-2000), Associate Professor (2001-2002) and Professor (2002-2008), Department for Research on Drug Addiction, St. Petersburg Medical Academy of Postgraduate Studies; Chief Professor and Head of the Department for Medical Research and Healthy Lifestyles, Herzen State Pedagogical University of Russia (2000-2008); Professor, Department for Conflict Studies, Faculty of Philosophy, St. Petersburg State University (2004- 2008); Member of numerous associations and societies, including: Association of Psychiatrists and Drug Addiction Specialists of Russia and St. Petersburg; Kettil Bruun Society for Social and Epidemiological Research on Alcohol; International Council on Alcohol and Addictions; International Society of Addiction Medicine: head of the sociology of science aspects of medical and biological research section of the Research Council on the Sociology of Science and the Organization of Scientific Research, St. Petersburg Scientific Centre of the Russian Academy of Sciences (2002-2008). Author of more than 100 publications, including more than 70 works published in the Russian Federation, chapters in monographs and several practical guides. Award for excellence in health protection, awarded by the Ministry of Health of the Union of Soviet Socialist Republics (1987). Consultant, Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria (since 2006); co-trainer, WHO programme “Skills for change” (since 1995); participant in meetings of the Commission on Narcotic Drugs (2002-2008); expert on the epidemiology of drug addiction, Pompidou Group of the Council of
Europe (1994-2003); temporary representative, WHO (1992-2008).
Member of the International Narcotics Control Board (2010).
Carola Lander
Born in 1941. National of Germany.
Pharmacist, doctoral degree in natural science; Certified Specialist in Public Health (Chamber of Pharmacists). Research assistant and assistant professor, University of Berlin (1970-1979); person in charge of pharmaceutical quality control of herbal drugs, Federal Institute for Drugs and Medical Devices, Berlin (1979-1990); head of the division for the control of manufacturers of narcotic drugs, Federal Opium Agency of Germany (1990-1992). Head of the Federal Opium Agency, the German authority with competence under article 17 of the Single Convention on Narcotic Drugs of 1961 and article 6 of the Convention on Psychotropic Substances of 1971, and Chairperson of the federal expert group for narcotic drugs (1992-2006). Member of the German delegation to the Commission on Narcotic Drugs (1990-2006). Lecturer on drug regulatory affairs, University of Bonn (2003-2005). Recipient of a certificate of appreciation for outstanding contributions in the field of drug law enforcement awarded by the Drug Enforcement Administration of the United States and recipient of a certificate of appreciation awarded by the former Yugoslav Republic of Macedonia.
Member of the International Narcotics Control Board (since 2007). Member (2007), Vice-Chairperson (2008) and Chairperson (2009) of the Standing Committee on Estimates. Second Vice-President of the Board (2009). First Vice-President of the Board (2010).
Melvyn Levitsky
Born in 1938. National of the United States. Retired Ambassador in the United States Foreign Service. Professor of International Policy and Practice and Senior Fellow, International Policy Center, Gerald R. Ford School of Public Policy, University of Michigan (since 2006). Faculty Associate, Center for Russian and East European Studies, Faculty Advisor, Weiser Center for Emerging Democracies,
133
Report of the International Narcotics Control Board
University of Michigan. Member of the Operating Committee, Substance Abuse Research Center, University of Michigan.
United States diplomat for 35 years, serving as, inter alia, Ambassador of the United States to Brazil (1994-1998); Assistant Secretary of State for International Narcotics Matters (1989-1993); Executive Secretary and Special Assistant to the Secretary of the United States Department of State (1987-1989); Ambassador of the United States to Bulgaria (1984-1987); Deputy Director, Voice of America (1983-1984); Deputy Assistant Secretary of State for Human Rights and Humanitarian Affairs (1982-1983); Director, Office of United Nations Political Affairs, Bureau of International Relations (1980-1982); Officer-in-Charge for Bilateral Relations, Office of Soviet Union Affairs (1975-1978); Political Officer, United States Embassy in Moscow (1973-1975); Consul, United States consulates in Frankfurt, Germany (1963-1965), and Belem, Brazil (1965-1967). Professor of International Relations and Public Administration, Maxwell School of Citizenship and Public Affairs, Syracuse University (1998-2006). Recipient of several United States Department of State Meritorious and Superior Honor Awards, Presidential Meritorious Service Awards and the United States Secretary of State’s Distinguished Service Award. Member of the Washington Institute of Foreign Affairs, the American Academy of Diplomacy and the American Foreign Service Association. Member of the Advisory Board, Drug Free America Foundation. Member of the Institute on Global Drug Policy. Member of the Board, Global Panel of the Prague Society. Member of the Public-Private Working Group on Sale of Controlled Substances via the Internet (Harvard University Law School). Distinguished Fellow, Daniel Patrick Moynihan Institute of Global Affairs, Maxwell School of Citizenship and Public Affairs, Syracuse University. Member of the University of Michigan Substance Abuse Research Center. Listed in Who’s Who in American Politics, Who’s Who in American Government and Who’s Who in American Education.
Member of the International Narcotics Control Board (since 2003). Chairman of the Committee on Finance and Administration (2004). Chairman of the Working Group on Strategy and Priorities (2005).
Marc Moinard
Born in 1942. National of France. Retired law officer. School of Political Sciences, Paris; Paris Law Faculty; Faculty of Arts, Poitiers. Public Prosecutor, Beuvais (1982-1983); Public Prosecutor, Pontoise (1990); Public Prosecutor, Lyon (1990-1991); Public Prosecutor, Bobigny (1992-1995); Public Prosecutor in the Court of Appeal, Bordeaux (1999-2005), introducing major reforms into the legal system involving: the creation of centres for legal advice and mediation; the provision of legal advice in deprived areas; the establishment of a new system of cooperation between the courts and the police services allowing for the immediate handling of criminal offences; and the creation of a new category of judicial personnel — assistant prosecutors.
Senior administrative posts in the Ministry of Justice: Director of Record Offices (1983-1986); President of the teaching board, National School of Clerks to the Court; Director of Legal Services; member of the Board of Directors, French National School for the Judiciary; Representative of the Minister of Justice in the Supreme Council of Justice (1995-1996); Director, Criminal Matters and Pardons (1996-1998); President, French Monitoring Centre for Drugs and Drug Addiction; Secretary-General, Ministry of Justice (2005-2008); President, Law and Justice Mission, responsible for the reform of the judicial map; President, Commission on Information Technology and Communication; Head of the International Affairs Service, Ministry of Justice. Lecturer, Paris Institute of Criminology (1995-2005); President, Fondation d’Aguesseau, a welfare body. Recipient of the following awards: Commander of the National Order of Merit; Commander of the Legion of Honour.
Member of the International Narcotics Control Board (2010).
Jorge Montaño
Born in 1948. National of Mexico. Professor of International Organizations and Mexican Foreign Policy, Instituto Tecnolôgico Autônomo de México, private consultant on the enforcement of the North American Free Trade Agreement (NAFTA).
134
Annex II. Current membership of the International Narcotics Control Board
Law and Political Science, Universidad Nacional Autônoma de México; Master of Arts and Doctor of Philosophy in International Affairs, London School of Economics. Director General de Educaciôn Superior — Secretaría de Educaciôn Pûblica (1976-1979); Member of the Mexican Foreign Service (1979-2008); Director of International Agencies (1979-1982); Assistant Secretary of Multilateral Affairs (1982-1988); Permanent Representative of Mexico to the United Nations organizations (1989-1992); Chairman of the Group of Experts to enhance the efficiency of the United Nations structure for drug abuse control (1990); Ambassador of Mexico to the United States (1993-1995); member of the Multilateral Evaluation Mechanism on drugs (2001-2003) of the Inter-American Drug Abuse Control Commission (CICAD). Author of the following publications: Partidos y política en América Latina; Implicaciones legales de la presencia de Estados Unidos en Viet Nam; Análisis del Sistema de Naciones Unidas; ACNUR en América Latina; Negociaciones del Tratado de Libre Comercio de America del Norte; Cooperaciôn México-Estados Unidos en materia de narcotráfico; Debilidades de la certificaciôn del Congreso de Estados Unidos; Retos de la frontera norte de México; Tráfico de armas en las fronteras mexicanas. Author of 50 articles published in specialized journals. Weekly contributor to the editorial pages of La Jornada, Reforma and El Universal. President and founding member of Foreign Affairs Latinoamérica (formerly Foreign Affairs en Español). Founding President, Asesoría y Análisis, S.C., Mexican Council on Foreign Relations (COMEXI). Recipient of awards from the Governments of Chile, El Salvador, Greece and Guatemala. Participant in many meetings of organizations in the United Nations system, the Organization of American States and the Movement of Non-Aligned Countries.
Member of the International Narcotics Control Board (2009). Member of the Committee on Finance and Administration (2010).
Lochan Naidoo
Born in 1961. National of South Africa. Family Practitioner, Durban, South Africa (since 1985).
Bachelor of Medicine and Bachelor of Surgery (MBChB), University of Natal, South Africa (1983). Professional in Residence Programme: Hanley
Hazelden (1995); Member of the South African Medical Association (since 1995); Member and Vice-Chairman of the Bayport Independent Practitioners Association (1995-2000). Certified Chemical Dependency Counsellor, National Board of Addiction Examiners (NBAE) (1996); Member of the American Society of Addiction Medicine (1996-1999). Diploma in Business Management, South African Institute of Management (1997). Founding member, International Society of Addiction Medicine (1999); Programme Designer and Principal Addictions Therapist of the Jullo Programme, a multi-disciplinary treatment model for primary, secondary and tertiary prevention of addiction disorders and dual diagnoses (since 1994); Clinical Director, Serenity Addiction Treatment Unit, Merebank, Durban, South Africa (since 1995). Member of the KwaZulu-Natal Managed Care Coalition (since 1995); Member of the Durban South Doctors’ Guild (since 2000); Honorary Lecturer, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, South Africa (since 2005). Curriculum Committee undergraduate Lifestyle Medicine,
University of KwaZulu-Natal (since 2005). Drafter of the National Detoxification Policy and Procedure for the Department of Health of South Africa (2006); designer of the Roots connect software program, an Internet-driven emotional and addiction psychoeducation delivery system (2007); Member of the Opiate Advisory Board of South Africa (2006-2008); Member of the Board, Central Drug Authority of South Africa (2006-2010); Member of the Governance Committee, Central Drug Authority of South Africa (2006-2010). Member of the Expert Committee on Opiate Treatment (2007-2008); Central Drug Authority representative to the Western Cape Province, South Africa (2007-2010); established “Roots HelpPoints” for early intervention and primary prevention among high-risk individuals (2008). Co-author of “Guidelines for opiate treatment in South Africa”, South African Medical Journal (2008). Member of the Suboxone Advisory Board (2009). Co-author of “Suboxone update”, South African Medical Journal (2010); Designer of “RehabFlow” cloud computing software for addiction and co-morbidity management (2010); Management Committee Member of eThekweni District Mental Heath and Substance Abuse Forum (2010). Rehabilitation and addictions trainer for health-care practitioners. Medical educator for undergraduate and postgraduate medical practitioners (since 1995); Patron
135
Report of the International Narcotics Control Board
of Andra Maha Sabha of South Africa; founder, Merebank West Community Coalition (1995). Trustee, Merebank Community Trust (2000-2005).
Member of the International Narcotics Control Board (since 2010).
Raj at Ray
Born in 1948. National of India. Professor and Head of the Department of Psychiatry and Chief, National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi.
Graduate of Medicine (MBBS), Medical College in Calcutta (1971). M.D. (Psychiatry), AIIMS (1977). Member of the faculty, Department of Psychiatry, National Institute of Mental Health and Neuro Sciences in Bangalore (1979-1988). Author of several technical reports and articles in peer reviewed national and international journals. Assistant Editor, Addiction Biology. Member of the International Advisory Board, Mental Health and Substance Use: Dual Diagnosis. Recipient of research support from various bodies at the national level (such as the Ministry of Health and Family Welfare and the Indian Council of Medical Research) and the international level (such as the United Nations Office on Drugs and Crime (UNODC) and WHO). Member of a study on HIV/AIDS, a collaborative project of NDDTC, AIIMS and the Center for Interdisciplinary Research in Immunology and Disease, University of California, Los Angeles (UCLA), United States of America. Member of the WHO Expert Advisory Panel on Drug Dependence and Alcohol Problems. Member of the expert group to discuss mental health and substance use disorder at the primary care level, an activity of the WHO Regional Office for South-East Asia. Member of the WHO expert group on regional technical consultation to reduce harmful use of alcohol. Coordinator of various activities in India on substance use disorder, sponsored by WHO (since 2004). Member of the National Drug Abuse Control Programme, India, and the Technical Guidelines Development Group on Pharmacotherapy of Opioid Dependence, a joint project of UNODC and WHO. Member and Chairperson of the Technical Resource Group on Injecting Drug Use, a project of the National AIDS Control Organization. Member of the project advisory committee on the prevention of transmission of HIV among drug users in South Asian Association for Regional Cooperation (SAARC) member States, a project of the UNODC Regional Office for South Asia. Member of the Subcommittee on Postgraduate Medical Education, Medical Council of India.
Member of the International Narcotics Control Board (2010). Member of the Standing Committee on Estimates (2010).
Viroj Sumyai
Born in 1953. National of Thailand. Retired Assistant Secretary-General of the Food and Drug Administration, Ministry of Public Health of Thailand, and clinical pharmacologist specializing in drug epidemiology. Professor, Mahidol University (since 2001).
Bachelor of Science degree in Chemistry (1976), Chiang Mai University. Bachelor’s degree in Pharmacy (1979), Manila Central University. Master’s degree in Clinical Pharmacology (1983), Chulalongkorn University. He then took apprenticeship in narcotic drugs epidemiology at St. George’s University of London in England in 1989. Doctor of Philosophy, Health Policy and Administration (2009), National Institute of Administration. Member of the Pharmaceutical Association of Thailand. Member of the Pharmacological and Therapeutic Society of Thailand. Member of the Thai Society of Toxicology. Author of nine books in the field of drug prevention and control, including Drugging Drinks: Handbook for Predatory Drugs Prevention and Déjà vu: A Complete Handbook for Clandestine Chemistry, Pharmacology and Epidemiology of LSD. Columnist, Food and Drug Administration Journal. Recipient of the Prime Minister Award for Drug Education and Prevention (2005).
Member of the International Narcotics Control Board (2010). Member of the Standing Committee on Estimates (2010).
Sri Suryawati
Born in 1955. National of Indonesia. Coordinator, Master Degree Program for Medicine Policy and Management, Gadjah Mada University. Senior Lecturer
136
Annex II. Current membership of the International Narcotics Control Board
in Pharmacology/Clinical Pharmacology (since 1980); supervisor for more than 120 master’s and doctoral theses on medicine policy, the rational use of medicines, clinical pharmacokinetics pharmacoeconomics, and pharmaceutical management.
Pharmacist (1979). Specialist in pharmacology (1985); doctoral degree in clinical pharmacokinetics (1994). Former Director of the Centre for Clinical Pharmacology and Medicine Policy Studies, Gadjah Mada University (2002-2010). Former Head of Clinical Pharmacology, Faculty of Medicine, Gadjah Mada University, Indonesia (1999-2006 and 2008-2009). Member of the WHO Expert Advisory Panel for Medicine Policy and Management. Member of the Executive Board of the International Network for the Rational Use of Drugs (INRUD). Member of the WHO Expert Committee on the Selection and Use of Essential Medicines (2002, 2003, 2005 and 2007). Member of the WHO Expert Committee on Drug Dependence (2002 and 2006). Member of the United Nations Millennium Project Task Force on HIV/AIDS, Malaria and Tuberculosis and Access to Essential Medicines (Task Force 5) (2001-2005). Consultant in essential medicine programmes and promoting rational use of medicines in Bangladesh (2006-2007), Cambodia (2001-2008), China (2006-2008), Fiji (2009), the Lao People’s Democratic Republic (2001-2003), Mongolia (2006-2008) and the Philippines (2006-2007). Consultant in medicine policy and drug evaluation in Cambodia (2003, 2005 and 2007), China (2003), Indonesia (2005-2006) and Viet Nam (2003). Facilitator in various international training courses in medicine policy and promoting the rational use of medicines, including WHO and INRUD courses on promoting the rational use of medicines (1994-2007), training courses on hospital drugs and therapeutics committees (2001-2007) and international courses on drug policy in developing countries (2002-2003).
Member of the International Narcotics Control Board (since 2007). Member (2008), Vice-Chair (2009) and Chair (2010) of the Standing Committee on Estimates. Second Vice-President of the Board (2010).
Camilo Uribe Granja
Born in 1963. National of Colombia. Medical Director, Maldonado Editorial Foundation, ILADIBA,
Bogota; Director Toxicology Unit, Clínica de Marly, Bogota (since 1990); Toxicologist, Clínica Palermo, Bogota (since 1994); Scientific Director, Unidad de Toxicología Integral (UNITOX), Hospital Infantil Universitario de San José (since 2008); Chief Coordinator, Clinic Toxicology, Hospital Infantil Universitario de San José, Bogota.
Medical doctor, Surgery, Faculty of Medicine, University of Our Lady of the Rosary (1989); specialization in clinical toxicology, Faculty of Medicine, University of Buenos Aires (1990); specialization in occupational toxicology (1997), University Teacher’s Certificate (1998), diplomas in hospital management (1998) and high-level social security administration (1999), High-Level Public Administration School (ESAP). Diploma in toxicological emergencies, University of Our Lady of the Rosary, FUNDASALUD (1998); diploma in higher education tuition, University of Our Lady of the Rosary. Forensic medical doctor, toxicologist, technical coordinator and manager in several hospitals and institutions. Medical Director, Hospital of San Martín, Meta, Colombia (1988); Head of Medical Attention, Caja de Previsiôn Social de Comunicaciones (CAPRECOM), Meta and national territories (until 1990); Regional Director, CAPRECOM, Bogota (until Dec. 1992); Scientific Director, Toxicology Clinic, toxicology advisory centre, “Guillermo Uribe Cualla” (1991-2005); Director, Clinical Toxicology, Clínica Fray Bartolomé de las Casas (until Jan. 1991); Toxicology Doctor, Clínica San Pedro Claver (1990-1991); President, Tropical Medicine Institute Corporation “Luis Patiño Camargo” (until 1992); Medical Coordinator and (since 1993) Director, National Emergency Network; Director, Toxicology Department, Hospital de Occidente Kennedy, Bogota (1993-1998); Director, Toxicology, Health Department, District of Bogota (1993-1999); Director, Health Services Management Programme, ESAP (until 2001); Member of the Steering Committee of Drugs and Food Control Administration, National Institute of Food and Drug Monitoring (INVIMA) (1994-2001); Director-General, INVIMA (2001-2002); Secretary, Colombian Medical Association, Cundinamarca and Bogota sections (until 2002); Director-General, Nueva Clínica Fray Bartolomé de las Casas, Bogota (2002-2003); Adviser to the toxicology office, United States Department of State (until 2005); Adviser in Toxicology, National Narcotics Directorate (DNE) of
137
Report of the International Narcotics Control Board
Colombia (until 2005). President, Colombian Association of Toxicology and Drug Abuse (ACOTOFA) (since 1992); Vice-President (1988-1990 and 1995-1998) and President (2003-2009), Latin American Toxicology Association (ALATOX); Vice-President, International Union of Toxicology (IUTOX) (2005-2007 and 2007-2009). Author of numerous works, including: the chapter on benzodiazepines in Therapeutic Compendium of the Colombian Internal Medicine Association (1992); Criminal Intoxication with Scopolamine-Like Substances; Handbook on Toxicological Emergency Management; and Manual on the Treatment of Intoxication by Plaguicides (1995). Recipient of numerous awards, including: award for academic records and qualifications, Iberoamerican Congress of Toxicology (Bicongretox), Spanish Association of Toxicolgy (AETOX) (1993); and honourable mention for services to Colombian society in the field of toxicology, First International Congress of Toxicology, University of Antioquia (1996). Participant in numerous professional conferences and seminars, including: XVIII International Congress of Internal Medicine, Bogota (1986); 35th Annual Meeting, Society of Toxicology, Anaheim, California (1996); Pan-American Congress of Neuropsychopharmacology and International Seminar on Addictive Diseases, Bogota (1998). National Congress on Heroin: A Challenge for Mental and Public Health, Medellin (2008); and International Congress on Synthetic Drugs (2009). Head of the Law Faculty, Pontificia Universidad Javeriana (1990-2006); Industrial Toxicology Professor, Colombian Security Council (until 1993); Postgraduate Professor, Fundación Universitaria Luis Amigó; and Instructor of Toxicology, Faculty of Medicine, National University of Colombia.
Member of the International Narcotics Control Board (since 2005). Member (since 2009), Vice-Chairman (2006 and 2007) and Chairman (2008) of the Standing Committee on Estimates; Member (since 2007) and Chair (2010) of the Committee on Finance and Administration.
Raymond Yans
Born in 1948. National of Belgium. Graduate in Germanic philology and in philosophy (1972). Belgian Foreign Service: Attaché, Jakarta (1978-1981);
Deputy-Mayor of Liège (1982-1989); Consul, Tokyo (1989-1994); Consul, Chargé d’affaires, Luxembourg (1999-2003); Head of the Drug Unit, Ministry of Foreign Affairs (1995-1999 and 2003-2007); Chairman of the Dublin Group (2002-2006); Chairman of the European Union Drug Policy Cooperation Working Group during the Belgian Presidency of the European Union; charged with the national coordination of the ratification and implementation process of the Convention on Psychotropic Substances of 1971 and the United Nations Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances of 1988 (1995-1998); liaison between the Ministry of Foreign Affairs and the National Police for drug liaison officers in Belgian embassies (2003-2005); participation in the launching by the European Union Joint Action on New Synthetic Drugs of an early warning system to alert Governments to the appearance of new synthetic drugs (1999); active in the creation of the Cooperation Mechanism on Drugs between the European Union, Latin America and the Caribbean (1997-1999). Author of numerous articles and speeches including: “The future of the Dublin Group” (2004) and “Is there anything such as a European Union Common Drug Policy” (2005). Member of the Belgian delegation to the Commission on Narcotic Drugs (1995-2007); all the preparatory sessions (on amphetamine-type stimulants, precursors, judicial cooperation, money-laundering, drug demand reduction and alternative development) for the twentieth special session of the General Assembly; European Union Seminar on Best Practices in Drug Enforcement by Law Enforcement Authorities, Helsinki (1999); Joint European Union/Southern African Development Community Conferences on Drug Control Cooperation, Mmabatho, South Africa (1995) and Gabarone (1998); United Nations Office on Drugs and Crime/Paris Pact round tables, Brussels (2003), Tehran and Istanbul (2005); meetings of the High-level Dialogue on Drugs between the Andean Community and the European Union, Lima (2005) and Vienna (2006).
Member of the International Narcotics Control Board (since 2007). Member of the Standing Committee on Estimates (2007 and 2010). Member of the Committee on Finance and Administration (since 2007). Rapporteur (2010).
138
Annex II. Current membership of the International Narcotics Control Board
Yu Xin
Born in 1965. National of China. Clinical Professor of Psychiatry, Institute of Mental Health, Peking University (since 2004). Licensed Psychiatrist, China Medical Association (since 1988). Founding President, Chinese Psychiatrist Association (2005-2008); Chairperson, Credential Committee for Psychiatrists, Ministry of Health of China; President-elect, Chinese Society of Psychiatry (since 2006); Vice-President, Management Association for
Psychiatric Hospitals (2009); Vice-Chairman, Alzheimer’s Disease, China (since 2002).
Bachelor of Medicine, Beijing Medical University (1988); Fellow in Psychiatry, University of Melbourne, Australia (1996-1997); Fellow in Substance Abuse, Johns Hopkins University (1998-1999); Doctor of Medicine (M.D.), Peking University (2000); Senior Fellow in Social Medicine, Harvard University (2003). Residency in psychiatry (1988-1993) and Psychiatrist (1993-1998), Institute of Mental Health, Beijing Medical University; Head, Associate Professor of Psychiatry, Geriatric Psychiatrist, Department of Geriatric Psychiatry, Institute of Mental Health, Peking University (1999-2001); Assistant Director (2000-2001) and Executive Director (2001-2004), Institute of Mental Health, Peking University. Author and co-author of numerous works on various topics in psychiatry, such as psychopharmacology, early intervention of schizophrenia, mental health and HIV/AIDS and drug use, mental health outcome of harmful alcohol use, neuropsychology of mental disorders, neuroimaging of late life depression, late onset psychosis, and assessment, treatment and care for dementia. Editor of several textbooks, including Geriatric Psychiatry, Textbook of Psychiatry for Asia and Psychiatry for Medical Students. Recipient of the Outstanding Clinician Award, Beijing Medical University, and the Innovation and Creation Award, Beijing Medical Professional Union (2004). Member of the expert group for the section on analgesics and sedatives of the State Food and Drug Administration (since 2000). Evaluator of the effectiveness of methadone clinics. Leader of a project to follow up the neurocognitive and mental functioning of patients infected with HIV/AIDS as a result of intravenous drug abuse. Chief Psychiatrist, National Community Mental Health Service Programme. Senior consultant, Chinese Association on Tobacco Control. Senior consultant, Chronic Pain Treatment Programme.
Member of the International Narcotics Control Board (since 2007). Chairman of the Committee on Finance and Administration (2009). Member (since 2007) and Vice-Chair (2010) of the Standing Committee on Estimates.